Cspc Innovation Pharmaceutical Co.,Ltd.’s Net Profit Rose 20.7% in First Half of 2023

Cspc Innovation Pharmaceutical Co.,Ltd. (石药集团新诺威制药股份有限公司) (300765.SZ) reported a net profit of 400.8 million yuan in the first half of 2023, up 20.7% year-on-year.

Meanwhile, the company posted 1.3 billion yuan in revenue, up 5.5% year-on-year.

At the end of the reporting period, it had 5.3 billion yuan in total assets and 539.4 million yuan in total liabilities, with a liability-to-asset ratio of 10.2%.